by Jim Miller and Janet Lowenbach, PharmSource Information Services The EU must harness market forces that reward innovation and competitiveness to combat its current R&D drain.
Janet Lowenbach
Advertisement
Articles by Janet Lowenbach
Advertisement
Latest Updated Articles
- Outsourcing Outlook: Will CROs find opportunity in a Reinvigorated European R&D Sector?
Published: November 15th 2002 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Formulation Strategies, Tech Advances, Challenges, and Considerations in Novel Drug Delivery
2
BioPharm Weekly News Roundup—Week of Nov. 24, 2025
3
Op-Ed: Why the US Must Move Beyond Its mRNA Monoculture
4
What a $2 Billion Maryland Expansion Means for the Future of Biologics Production
5
